Treatment,Gene,Level,Total
"Cetuximab,Panitumumab;","KRAS p.A146T","Level R1",20
"Cetuximab,Panitumumab;","KRAS p.G12C","Level R1",24
"Not provided","Not provided","Level R1",414
"Cetuximab,Panitumumab;","KRAS p.G12D","Level R1",92
"Cetuximab,Panitumumab;","NRAS p.Q61L","Level R1",4
"Cetuximab,Panitumumab;","KRAS p.G12V","Level R1",61
"Cetuximab,Panitumumab;","KRAS p.G13D","Level R1",47
"Cetuximab,Panitumumab;","KRAS p.V14I","Level R1",1
"Cetuximab,Panitumumab;","KRAS p.Q61H","Level R1",6
"Cetuximab,Panitumumab;","NRAS p.Q61K","Level R1",8
"Cetuximab,Panitumumab;","KRAS p.G12R","Level R1",4
"Cetuximab,Panitumumab;","NRAS p.G12D","Level R1",5
"Cetuximab,Panitumumab;","KRAS p.G12A","Level R1",14
"Cetuximab,Panitumumab;","KRAS p.G12S","Level R1",13
"Cetuximab,Panitumumab;","KRAS p.K117N","Level R1",5
"Cetuximab,Panitumumab;","KRAS p.A146V","Level R1",4
"Cetuximab,Panitumumab;","KRAS p.G12F","Level R1",1
"Cetuximab,Panitumumab;","NRAS p.G12V","Level R1",1
"Cetuximab,Panitumumab;","KRAS p.G13C","Level R1",2
"Cetuximab,Panitumumab;","NRAS p.G12C","Level R1",3
"Cetuximab,Panitumumab;","KRAS p.G12A;NRAS p.Q61K","Level R1",1
"Cetuximab,Panitumumab;","KRAS p.D33E","Level R1",1
"Cetuximab,Panitumumab;","KRAS p.Q61R","Level R1",2
"Cetuximab,Panitumumab;","KRAS p.G12V;KRAS p.G12A","Level R1",1
"Cetuximab,Panitumumab;","KRAS p.G12V;KRAS p.D33E","Level R1",1
"Not provided","Not provided","Level 2B",635
Crizotinib;,"MET Amplification","Level 2B",8
"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib;","BRAF p.V600E","Level 2B",44
"ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab;","ERBB2 Amplification","Level 2B",29
"Erlotinib,Gefitinib,Afatinib;","EGFR p.L861Q","Level 2B",2
Olaparib;,"BRCA2 p.D1868Vfs*5","Level 2B",1
Olaparib;,"BRCA2 p.Q1551*","Level 2B",1
"Olaparib;Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib;","BRAF p.V600E;BRCA2 p.T3085Nfs*26","Level 2B",1
Olaparib;,"BRCA2 p.S1442*","Level 2B",1
Olaparib;,"BRCA2 p.X3215_splice","Level 2B",1
Olaparib;,"BRCA2 p.F1978Lfs*26;BRCA2 p.K3416Nfs*11","Level 2B",1
Olaparib;,"BRCA2 p.L1545Rfs*3","Level 2B",1
Everolimus;,"TSC2 p.X325_splice","Level 2B",1
Everolimus;,"TSC1 p.X122_splice","Level 2B",1
"Olaparib;Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib;","BRAF p.V600E;BRCA2 p.K3416Nfs*11","Level 2B",1
Olaparib;,"BRCA2 p.T1359Yfs*2","Level 2B",1
Everolimus;,"TSC2 p.W896del","Level 2B",1
Everolimus;,"TSC1 p.N891Kfs*13","Level 2B",1
Olaparib;,"BRCA1 p.L1564P;BRCA1 p.Q210Sfs*6","Level 2B",1
"ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab;Crizotinib;","ERBB2 Amplification;MET Amplification","Level 2B",1
Olaparib;,"BRCA2 p.L638*","Level 2B",1
Olaparib;Everolimus;Crizotinib;,"MET p.X1087_splice;TSC1 p.E218*;BRCA2 p.K3032*","Level 2B",1
"Not provided","Not provided","Level 3A",729
"LOXO-101,Entrectinib;","NTRK3 LEVEL_3B","Level 3A",1
Panitumumab;,"EGFR p.S492R","Level 3A",1
LOXO-101;,"NTRK1 LEVEL_3A","Level 3A",4
"Not provided","Not provided","Level 3B",528
"Sonidegib,Vismodegib;","PTCH1 p.E992*","Level 3B",1
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib;","NRAS p.Q61L","Level 3B",4
"AZD4547,Dovitinib;","FGFR1 Amplification","Level 3B",11
"Lapatinib+Trastuzumab,Neratinib;","ERBB2 Amplification","Level 3B",24
alpelisib;,"PIK3CA p.E545K","Level 3B",38
alpelisib;,"PIK3CA p.C420R","Level 3B",2
Neratinib;,"ERBB2 p.I767M","Level 3B",1
alpelisib;,"PIK3CA p.E542K","Level 3B",17
alpelisib;,"PIK3CA p.R38C","Level 3B",3
"Lapatinib+Trastuzumab,Neratinib;Neratinib;","ERBB2 Amplification;ERBB2 p.V842I","Level 3B",2
alpelisib;,"PIK3CA p.Q546K","Level 3B",6
"Cobimetinib,Trametinib,Selumetinib;","MAP2K1 p.K57E","Level 3B",2
alpelisib;,"PIK3CA p.E365K","Level 3B",2
alpelisib;,"PIK3CA p.H1047R","Level 3B",10
"AZD4547,Dovitinib;alpelisib;","FGFR1 Amplification;PIK3CA p.E542K","Level 3B",2
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib;","NRAS p.Q61K","Level 3B",6
alpelisib;,"PIK3CA p.N345K","Level 3B",2
alpelisib;,"PIK3CA p.E542K;PIK3CA p.M1043I","Level 3B",1
alpelisib;,"PIK3CA p.H1047R;PIK3CA p.G118D","Level 3B",1
alpelisib;,"PIK3CA p.Q546K;PIK3CA p.E726K","Level 3B",1
LEVEL_3B;,"NTRK3 LEVEL_3B","Level 3B",1
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib;","NRAS p.G12D","Level 3B",5
alpelisib;,"PIK3CA p.H1047Y","Level 3B",1
"Cobimetinib,Trametinib,Selumetinib;","MAP2K1 p.K57N","Level 3B",1
alpelisib;,"PIK3CA p.H1047R;PIK3CA p.R93Q","Level 3B",1
Trametinib;,"BRAF p.K601E","Level 3B",1
"Cobimetinib,Trametinib,Selumetinib;alpelisib;","MAP2K1 p.K57T;PIK3CA p.*1069F","Level 3B",1
AZD5363;,"AKT1 p.E17K","Level 3B",5
Neratinib;,"ERBB2 p.S310F","Level 3B",1
"alpelisib;Lapatinib+Trastuzumab,Neratinib;","ERBB2 Amplification;PIK3CA p.G1049R","Level 3B",1
"Sonidegib,Vismodegib;","PTCH1 p.L39Cfs*41","Level 3B",1
alpelisib;,"PIK3CA p.E545K;PIK3CA p.E542K","Level 3B",1
"Sorafenib,Sorafenib;","ARAF p.S214P","Level 3B",1
Crizotinib;,"ALK p.R1275Q","Level 3B",1
"Cobimetinib,Trametinib,Selumetinib;","MAP2K1 p.E203K","Level 3B",1
alpelisib;,"PIK3CA p.Q546P","Level 3B",2
alpelisib;,"PIK3CA p.G1049R","Level 3B",2
"alpelisib;Lapatinib+Trastuzumab,Neratinib;","ERBB2 Amplification;PIK3CA p.H1047R","Level 3B",1
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib;","NRAS p.G12V","Level 3B",1
alpelisib;,"PIK3CA p.N345I","Level 3B",1
"Lapatinib+Trastuzumab,Neratinib;Neratinib;","ERBB2 Amplification;ERBB2 p.V777L","Level 3B",2
alpelisib;,"PIK3CA p.M1043L","Level 3B",1
alpelisib;,"PIK3CA p.E545G","Level 3B",2
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib;","NRAS p.G12C","Level 3B",3
"alpelisib;Sonidegib,Vismodegib;","PIK3CA p.H1047R;PIK3CA p.R88Q;PTCH1 p.P1202Lfs*53","Level 3B",1
Neratinib;,"ERBB2 p.V842I","Level 3B",1
"alpelisib;Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib;","NRAS p.Q61K;PIK3CA p.N345K","Level 3B",1
"AZD5363;Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib;","AKT1 p.E17K;NRAS p.Q61K","Level 3B",1
AG-120;,"IDH1 p.R132C","Level 3B",2
Entrectinib;,"NTRK1 LEVEL_3A","Level 3B",4
"Cobimetinib,Trametinib,Selumetinib;Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib;","NRAS p.Q61K;MAP2K1 p.G128V","Level 3B",1
alpelisib;,"PIK3CA p.G106_R108del","Level 3B",1
"alpelisib;Sonidegib,Vismodegib;","PIK3CA p.R38H;PTCH1 p.C454Ffs*2","Level 3B",1
"Cobimetinib,Trametinib,Selumetinib;","MAP2K1 p.E102_I103del;MAP2K1 p.E102_I103del","Level 3B",1
alpelisib;,"PIK3CA p.G118D","Level 3B",2
alpelisib;,"PIK3CA p.R88Q","Level 3B",2
alpelisib;,"PIK3CA p.R108H","Level 3B",2
alpelisib;,"PIK3CA p.E453K","Level 3B",1
"Cobimetinib,Trametinib,Selumetinib;","MAP2K1 p.Y130C","Level 3B",1
"Sonidegib,Vismodegib;","PTCH1 p.S1203Afs*52","Level 3B",1
"alpelisib;Capmatinib,Cabozatinib;","PIK3CA p.R38H;MET p.X1087_splice","Level 3B",1
Neratinib;,"ERBB2 p.V777L","Level 3B",1
alpelisib;,"PIK3CA p.G106R","Level 3B",1
alpelisib;,"PIK3CA p.H1047R;PIK3CA p.Q546R","Level 3B",1
AG-221;,"IDH2 p.R172K","Level 3B",1
alpelisib;,"PIK3CA p.Q546R","Level 3B",1
Trametinib;alpelisib;,"PIK3CA p.E545K;BRAF p.K601E","Level 3B",1
alpelisib;,"PIK3CA p.C378R","Level 3B",1
alpelisib;AG-221;,"PIK3CA p.E542K;IDH2 p.R172K","Level 3B",1
Neratinib;,"ERBB2 p.D769Y","Level 3B",1
